4.7 Article

Two-year follow-up of treated adolescents with early-onset bipolar disorder: Changes in neurocognition

期刊

JOURNAL OF AFFECTIVE DISORDERS
卷 172, 期 -, 页码 48-54

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jad.2014.09.041

关键词

Bipolar disorder; Adolescent; Cognition; Control group; Follow-up study

资金

  1. CIBERSAM (Madrid, Spain)
  2. Alicia Koplowitz Foundation (Madrid, Spain)

向作者/读者索取更多资源

Background: Few studies have analyzed the course of neurocognition in treated children and adolescents with early-onset bipolar disorder (FOOD) and shown improvements in attention, working memory, and verbal memory after treatment. The aim of this study was to determine the progress over two years in neuropsychological performance of a sample of medicated adolescents with FOOD compared to healthy controls (HC). Methods: Twenty adolescents, diagnosed in clinical setting as DSM4V bipolar disorder, treated for two years, euthymic, and 20 gender and age-matched HC were assessed at two moments in reasoning, verbal and visual memory, working memory, speed, visual-motor skills and executive function. Multivariate analyses of variance was carried out to analyze the differences between groups over time, and to monitor the influence of psychotic symptoms and type of mood-stabilizer. Results: The entire sample improved on verbal and visual memory tests (verbal recall p < 0.01; visual recall p < 0.001). Moreover, patients improved more than controls in verbal reasoning (p <0.01), working memory (p 001), processing speed (p < 0.01) and visual-motor skills (p < 0.001). Psychotic symptoms and treatment with lithium were associated with poorer development in executive control tasks. Limitations: Sample size was small and groups were re-evaluated in slight different follow-up periods Doses of antipsychotics drugs over time were not controlled. Conclusions: Processing speed and visual-motor skills in the EOBD group normalized during follow-up. Executive functioning, working memory, and verbal and visual memory remained impaired in patients versus controls. The knowledge of cognitive deficits clue to normal course of illness or to drug effects allows better therapeutic strategies. (C) 2014 Elsevier B.V. All rights reserved

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据